Table 2.

Overall survival of NSCLC patients in relation to clinicopathologic characteristics and miR-25 expression.

	Univariate analysis		Multivariate analysis
Variable (n= 67)	Hazard ratio (95% CI)	p	Hazard ratio (95% CI)	p
Differentiation (well+ moderate/poor)	2.35 (1.07–5.14)	0.085
N (N1/N0)	2.75 (1.27–5.546)	0.006
TNM stage (I+ II/III)	2.98(1.26–4.17)	0.023	3.14(1.42–4.94)	0.043
miR-25 (low/high)	1.93(0.98–4.14)	0.004	1.84(1.07–5.74)	0.012